Chemodex

Xanthohumol

CHF 299.00
In stock
CDX-X0005-M02525 mgCHF 299.00
CDX-X0005-M05050 mgCHF 474.00
More Information
Product Details
Synonyms 2',4,4'-Trihydroxy-6'-methoxy-3'-prenylchalcone
Product Type Chemical
Properties
Formula

C21H22O5

MW 354.4
CAS 6754-58-1
RTECS UD5574117
Source/Host Chemicals Plant
Purity Chemicals ≥98% (NMR)
Appearance Yellow powder.
Solubility Soluble in DMSO (10mg/ml) or ethanol (10mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key ORXQGKIUCDPEAJ-YRNVUSSQSA-N
Smiles OC1=C(C(/C=C/C2=CC=C(O)C=C2)=O)C(OC)=CC(O)=C1C/C=C(C)/C
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Xanthohumol is a cell-permeable natural prenylated chalcone isolated from the hop plant, H. lupulus. Xanthohumol and its metabolites induce protective detoxification enzymes, at least in part via the nuclear factor erythroid-2-related factor 2 pathway. Xanthohumol can have anti-inflammatory, antioxidant, anticarcinogenic, antidiabetic and osteogenic effects. Xanthohumol binds to the N-terminal domain of p97 ATPase (VCP; valosin-containing protein), an essential protein for autophagosome maturation. Xanthohumol inhibits the function of p97 ATPase thereby impairing autophagosome maturation and resulting in accumulation of the microtubule-associated protein 1 light chain 3-II (LC3-II)1. Xanthohumol inhibits diacylglycerol acetyltransferase (DGAT) and human P450 enzymes. It also inhibits the expression of HIF-1α and VEGF under hypoxic conditions.

Product References

(1) N. Tabata, et al.; Phytochemistry 46, 683 (1997) | (2) J.F. Stevens & J.E. Page; Phytochemistry 65, 1317 (2004) (Review) | (3) C. Gerhauser; Mol. Nutr. Food Res. 49, 827 (2005) (Review) | (4) P.J. Magalhaes, et al.; Nat. Prod. Commun. 4, 591 (2009) (Review) | (5) J. Inokoshi, et al.; J. Antibiot. 62, 51 (2009) | (7) R. Vene, et al.; Mol. Med. 18, 1292 (2012) | (8) Y. Sasazawa, et al.; ACS Chem. Biol. 7, 892 (2012) | (9) V. Krajka-Kuzniak, et al.; Toxicol. In Vitro 27, 149 (2013) | (10) R. Costa, et al.; J. Nat. Prod. 76, 2047 (2013) | (11) T. Schilling, et al.; J. Ster. Biochem. Mol. Biol. 139, 252 (2014) | (12) M. Liu, et al.; Molecules 20, 754 (2015) (Review) | (13) C.H. Jiang, et al.; Front. Pharmacol. 9, 530 (2018) (Review)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.